Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE: THE EXEMPLE OF TYPE 2 DIABETES].

Revue medicale de Liege - 1 Jan 2000

Paquot N

Abstract excerpt

Type 2 diabetes represents a major medical and public health problem due to its huge heterogeneity, the alarming rise of its incidence worldwide and its associated vascular complications, which impair quality of life and reduce life expectancy. At the present time, a patient-centered approach is recommended for the management of type 2 diabetes patients. However, these recommendations are not easy to implement...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Evidence-Based Medicine
Share to Hypoglycemic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metformin

Share to Phenotype

Share to Precision Medicine

Source

Identifiers

PMID: 26285456

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE: THE EXEMPLE OF TYPE 2 DIABETES].PMID 26285456Read ↗

[Perspective for personalized medicine for diabetes].Semantic proximity Read ↗

Personalized therapy algorithms for type 2 diabetes: a phenotype-based approachSemantic proximity Read ↗

[Individualized prevention of type 2 diabetes].Semantic proximity Read ↗

[Personalized medicine and type-2 diabetes: pharmakogenetic aspects of drug therapy].Semantic proximity Read ↗

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineSemantic proximity Read ↗

Multifaceted therapeutic approaches for a multigenic disease.Semantic proximity Read ↗

[A journey towards precision medicine in type 1 diabetes mellitus].Semantic proximity Read ↗

[Molecular and therapeutic progress in diabetes: future perspectives].Semantic proximity Read ↗

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical PracticeSemantic proximity Read ↗

Precision medicine in the management of type 2 diabetes.Semantic proximity Read ↗

[MODY diabetes: differences in the clinical picture caused by genetic heterogeneity in clinical practice].Semantic proximity Read ↗

Current progress in pharmacogenomics of Type 2 diabetes: A systemic overview.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.